ArticleLeukemia2017

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia.

I-K Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.